Dr. Florencia P. Segal

Kenneth Mayer is an Infectious Disease provider practicing medicine in Boston, Massachusetts. Dr. Mayer is highly rated in 9 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Syphilis, Gonorrhea, Chlamydia, and Tissue Biopsy.

Dr. Paul E. Sax is Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital (BWH), where he holds the Bruce and Robert Beal Distinguished Chair, and Professor of Medicine at Harvard Medical School. Dr. Sax received his MD from Harvard Medical School, did his residency in Internal Medicine at BWH, then fellowship in Infectious Diseases at Massachusetts General Hospital.He is Editor-in-Chief of Open Forum Infectious Diseases, is Section Editor of HIV/AIDS in UpToDate, on the Editorial Board of NEJM Journal Watch Infectious Diseases (where he writes the HIV and ID Observations blog), and on the editorial advisory board of Medscape HIV/AIDS. Dr. Sax is the Associate Program Director for the Mass General Brigham fellowship in Infectious Diseases, is on the core faculty of the International Antiviral Society – USA, and teaches regularly on HIV and infectious diseases locally, nationally, and internationally. In addition to his clinical practice and teaching, Dr. Sax’s ongoing areas of research include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy. He is presently the principal investigator at the BWH AIDS Clinical Trials Unit, and is a member of the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) Research Group. Dr. Sax is highly rated in 7 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Nontuberculous Mycobacterial Lung Disease, Myelitis, and AIDS Dementia Complex. Dr. Sax is board certified in Internal Medicine and Infectious Disease.

Daniel R. Kuritzkes, MD received his BS and MS degrees in Molecular Biophysics and Biochemistry from Yale University, and his MD from Harvard Medical School.  He completed his clinical and research training in internal medicine and infectious diseases at Massachusetts General Hospital and was a visiting scientist at the Whitehead Institute for Biomedical Research before joining the faculty at the University of Colorado Health Sciences Center.  Dr. Kuritzkes returned to Harvard Medical School in 2002, where he is now the Harriet Ryan Albee Professor of Medicine and Chief, Division of Infectious Diseases at Brigham and Women’s Hospital.  Dr. Kuritzkes has published extensively on antiretroviral therapy and drug resistance in HIV-1 infection.  He has chaired several multicenter studies of HIV therapy and previously chaired the AIDS Clinical Trials Group.  He has served on numerous NIH committees, including as a member of the NIH Office of AIDS Research Advisory Council.  He is a former member of the Department of Health and Human Services panel on guidelines for antiretroviral therapy and a past Chair of the HIV Medicine Association Board of Directors.  He has been a member of several editorial boards, and serves as an Associate Editor of the Journal of Infectious Diseases.  His research interests focus on HIV therapeutics, antiretroviral drug resistance, HIV eradication and more recently, COVID-19. Dr. Kuritzkes is highly rated in 5 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Kuritzkes is board certified in Internal Medicine and Infectious Disease.